The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Role of HLA class-I antigen peptide loading complex components in immune evasion and treatment sensitivity in human lung cancer.
 
Adrien Costantini
No Relationships to Disclose
 
Kishu Ranjan
No Relationships to Disclose
 
Soldano Ferrone
No Relationships to Disclose
 
Kurt A. Schalper
Consulting or Advisory Role - Agenus; AstraZeneca; Bristol Myers Squibb; CDR-Life; Clinica Alemana; EMD Serono; Molecular Templates; OnCusp Therapeutics; Parthenon Therapeutics; Roche; Shattuck Labs; Takeda
Speakers' Bureau - Bristol-Myers Squibb; Forefront Collaborative; Genmab; Merck; Peerview; Takeda
Research Funding - Akoya Biosciences (Inst); AstraZeneca; Boehringer Ingelheim (Inst); Bristol-Myers Squibb; Lilly; Merck; Navigate BioPharma; Ribon Therapeutics; Roche (Inst); Surface Oncology; Takeda; Tesaro (Inst)
Patents, Royalties, Other Intellectual Property - Patent No. 16/464,010 (PREDICTION OF RESPONSE TO IMMUNE-MODULATORY THERAPIES)
Expert Testimony - AstraZeneca